共 12 条
- [1] Low dose(5mg) simvastation verus gem-fibrozil in the treatment of primary moderate hyperc-holesterolemia: Result of a Belgian Multicenter Study. Ducobu I. Current Therapeutic Research . 1989
- [2] Effect of simvastatin on coronary atheroma: the Multicenter Anti-AtheromaStudy(MAAS). The MAAS investigators. The Lancet . 1994
- [3] Lovastatin(Mevinolin) in the treatment of heterozygons familial hyperoholesterolemia. Havel RI,Hunninghake DB. Illingworth DR,et al. Annals of Internal Medicine . 1987
- [4] Newman TB,Hulley SB,Carcinogenicity of lipid-lowering. The Journal of The American Medical Association . 1996
- [5] Comparism of properties of four inhibitors of 3-hydroxy-3-methylglutary--coenzyme A rednc-tase. Blum CB. The American Journal of Cardiology . 1994
- [6] Prevention of restenosis after coronary balloon angioplasty: rational(FlARE) trial. Foley DP. Bonnier H,Jackson G,et al. The American Journal of Cardiology . 1994
- [7] Compari-son of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. The Simvastatin Pravastatin Study Group. The American Journal of Cardiology . 1993
- [8] Effects of synvinolin(MK-733) on plasma lipids in familial hypercholesterolemia. Mol MJ,Erkelens DW,Gevers Leuven IA,et al. The Lancet . 1986
- [9] Reducing the risk of coronary events: evidence from the Scandinavian simvas-tatin survival study(4s). Kjekshus J,Pedersen TR. The American Journal of Cardiology . 1995
- [10] Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Sandinavian Simvastatin Survival Study(4s). Scandinavian Simvastatin Survival study Group. The Lancet . 1994